Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,878 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Khorrami M, Bera K, Leo P, Vaidya P, Patil P, Thawani R, Velu P, Rajiah P, Alilou M, Choi H, Feldman MD, Gilkeson RC, Linden P, Fu P, Pass H, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: fu p. Lung Cancer. 2020 Apr;142:90-97. doi: 10.1016/j.lungcan.2020.02.018. Epub 2020 Feb 26. Lung Cancer. 2020. PMID: 32120229 Free PMC article.
CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction.
Vaidya P, Bera K, Gupta A, Wang X, Corredor G, Fu P, Beig N, Prasanna P, Patil P, Velu P, Rajiah P, Gilkeson R, Feldman M, Choi H, Velcheti V, Madabhushi A. Vaidya P, et al. Among authors: fu p. Lancet Digit Health. 2020 Mar;2(3):e116-e128. doi: 10.1016/s2589-7500(20)30002-9. Epub 2020 Feb 13. Lancet Digit Health. 2020. PMID: 32123864 Free PMC article.
CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P, Bera K, Gupta A, Wang X, Corredor G, Fu P, Beig N, Prasanna P, Patil PD, Velu PD, Rajiah P, Gilkeson R, Feldman MD, Choi H, Velcheti V, Madabhushi A. Vaidya P, et al. Among authors: fu p. Lancet Digit Health. 2020 Mar;2(3):e116-e128. doi: 10.1016/S2589-7500(20)30002-9. Epub 2020 Feb 13. Lancet Digit Health. 2020. PMID: 33334576 Free article.
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction models.
Dharmavaram G, Cao S, Sundaram S, Ayyappan S, Boughan K, Gallogly M, Malek E, Metheny L, Tomlinson B, Otegbeye F, Lazarus HM, Cooper B, Fu P, de Lima M, Caimi PF. Dharmavaram G, et al. Among authors: fu p. Am J Hematol. 2020 Aug;95(8):918-926. doi: 10.1002/ajh.25837. Epub 2020 May 8. Am J Hematol. 2020. PMID: 32311162 Free article.
2,878 results